We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.41%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$67.1B
AUM Growth
-$1.4B
(-2%)
Cap. Flow
+$2.19B
Cap. Flow
% of AUM
3.26%
Top 10 Holdings %
Top 10 Hldgs %
22.03%
Holding
3,122
New
29
Increased
2,768
Reduced
217
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$146M |
| 2 |
Apple
AAPL
|
+$75.7M |
| 3 |
Tesla
TSLA
|
+$70.4M |
| 4 |
Amazon
AMZN
|
+$65M |
| 5 |
Procter & Gamble
PG
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$27.2M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$21.1M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$19.2M |
| 4 |
COHR
Coherent Inc
COHR
|
+$18.8M |
| 5 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.62% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Impinj
PI
$5.6B
| $2.22M | ﹤0.01% |
27,700
+2,222
| +9% | +$185K |
|
|
AHRT
1702
AH Realty Trust
AHRT
$517M
| $2.21M | ﹤0.01% |
213,162
+8,312
| +4% | +$109K |
|
1703
1st Source
SRCE
$2.12B
| $2.21M | ﹤0.01% |
47,767
+5,235
| +12% | +$249K |
|
1704
Carvana
CVNA
$77.9B
| $2.21M | ﹤0.01% |
544,665
+64,330
| +13% | +$420K |
|
1705
Cass Information Systems
CASS
$743M
| $2.2M | ﹤0.01% |
63,501
+12,619
| +25% | +$453K |
|
|
VERV
1706
DELISTED
Verve Therapeutics
VERV
| $2.2M | ﹤0.01% |
64,067
+13,304
| +26% | +$425K |
|
1707
Perdoceo Education
PRDO
$2.12B
| $2.19M | ﹤0.01% |
212,902
+7,315
| +4% | +$87.4K |
|
1708
Hanmi Financial
HAFC
$946M
| $2.19M | ﹤0.01% |
92,460
+3,232
| +4% | +$79.3K |
|
1709
Tronox
TROX
$1.04B
| $2.18M | ﹤0.01% |
178,062
+13,012
| +8% | +$193K |
|
1710
Recursion Pharmaceuticals
RXRX
$1.73B
| $2.18M | ﹤0.01% |
204,724
+16,058
| +9% | +$163K |
|
1711
Virtu Financial
VIRT
$4.93B
| $2.18M | ﹤0.01% |
104,813
+7,682
| +8% | +$176K |
|
1712
Artisan Partners
APAM
$3.02B
| $2.18M | ﹤0.01% |
80,786
+5,797
| +8% | +$204K |
|
|
CUTR
1713
DELISTED
Cutera, Inc.
CUTR
| $2.17M | ﹤0.01% |
47,604
+3,553
| +8% | +$162K |
|
1714
Krystal Biotech
KRYS
$9.66B
| $2.17M | ﹤0.01% |
31,123
+2,638
| +9% | +$191K |
|
1715
E.W. Scripps
SSP
$304M
| $2.16M | ﹤0.01% |
191,857
+7,279
| +4% | +$103K |
|
|
TRST
1716
Trustco Bank Corp NY
TRST
$938M
| $2.16M | ﹤0.01% |
68,726
+1,750
| +3% | +$58K |
|
|
FLNA
1717
Filana Therapeutics
FLNA
$48.1M
| $2.15M | ﹤0.01% |
51,407
+4,625
| +10% | +$125K |
|
1718
Helios Technologies
HLIO
$2.76B
| $2.15M | ﹤0.01% |
42,397
+2,926
| +7% | +$177K |
|
|
MAXR
1719
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $2.14M | ﹤0.01% |
114,556
+8,566
| +8% | +$210K |
|
1720
Appian
APPN
$2.48B
| $2.14M | ﹤0.01% |
52,428
+2,177
| +4% | +$106K |
|
|
PGRE
1721
DELISTED
Paramount Group
PGRE
| $2.14M | ﹤0.01% |
343,472
+29,723
| +9% | +$214K |
|
1722
Upwork
UPWK
$1.19B
| $2.14M | ﹤0.01% |
157,049
+9,601
| +7% | +$181K |
|
1723
Gogo Inc
GOGO
$492M
| $2.13M | ﹤0.01% |
176,012
+2,670
| +2% | +$40.6K |
|
|
SGFY
1724
DELISTED
Signify Health, Inc.
SGFY
| $2.13M | ﹤0.01% |
73,188
+9,712
| +15% | +$224K |
|
1725
Innoviva
INVA
$1.48B
| $2.13M | ﹤0.01% |
183,600
+3,767
| +2% | +$51.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, RhumbLine Advisers held 3,122 positions worth $67.1B, down 2% from $68.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2.19B of net new capital in Q3 2022, opening 29 new positions and adding to 2,768 existing holdings. Its largest new stake was Enhabit: 136,327 shares worth $1.91M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $21.1M trimmed.
- RhumbLine Advisers's largest Q3 2022 buy was Enhabit: 136,327 shares worth $1.91M.
- RhumbLine Advisers added most to Microsoft in Q3 2022, an estimated $146M increase.
- RhumbLine Advisers's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21.1M.
- RhumbLine Advisers fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $27.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $67.1B portfolio in Q3 2022.
- RhumbLine Advisers opened 29 new positions and closed 40 in Q3 2022.
- RhumbLine Advisers's portfolio value fell 2% quarter-over-quarter to $67.1B.
Based on RhumbLine Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.